Related Experiment Video
Updated: Feb 2, 2026

Synthesis of Protein Bioconjugates via Cysteine-maleimide Chemistry
Published on: July 20, 2016
Synthesis, in vitro stability, and antiproliferative effect of d-cysteine modified GnRH-doxorubicin conjugates
Songtao Li1, Hongling Zhao1, Xiaomin Chang2
1Hebei Province Key Laboratory of Research and Development of Traditional Chinese Medicine, Chengde Medical University, Chengde, Hebei, 067000, China.
Abstract:
Overexpression of gonadotropin-releasing hormone (GnRH) receptor in many tumors but not in normal tissues makes it possible to use GnRH analogs as targeting peptides for selective delivery of cytotoxic agents, which may help to enhance the uptake of anticancer drugs by cancer cells and reduce toxicity to normal cells. The GnRH analogs [d-Cys6 , desGly10 , Pro9 -NH2 ]-GnRH, [d-Cys6 , desGly10 , Pro9 -NHEt]-GnRH, and [d-Cys6 , α-aza-Gly10 -NH2 ]-GnRH were conjugated with doxorubicin (Dox), respectively, through N-succinimidyl-3-maleimidopropionate as a linker to afford three new GnRH-Dox conjugates. The metabolic stability of these conjugates in human serum was determined by RP-HPLC. The antiproliferative activity of the conjugates was examined in GnRH receptor-positive MCF-7 human breast cancer cell line by MTT assay. The three GnRH-Dox conjugates showed improved metabolic stability in human serum in comparison with AN-152. The antiproliferative effect of conjugate II ([d-Cys6 , desGly10 , Pro9 -NHEt]-GnRH-Dox) on MCF-7 cells was higher than that of conjugate I ([d-Cys6 , desGly10 , Pro9 -NH2 ]-GnRH-Dox) and conjugate III ([d-Cys6 , α-aza-Gly10 -NH2 ]-GnRH-Dox), and the cytotoxicity of conjugate II against GnRH receptor-negative 3T3 mouse embryo fibroblast cells was decreased in comparison with free Dox. GnRH receptor inhibition test suggested that the antiproliferative activity of conjugate II might be due to the cellular uptake mediated by the targeting binding of [d-Cys6 -des-Gly10 -Pro9 -NHEt]-GnRH to GnRH receptors. Our study indicates that targeting delivery of conjugate II mediated by [d-Cys6 -des-Gly10 -Pro9 -NHEt]-GnRH is a promising strategy for chemotherapy of tumors that overexpress GnRH receptors.
Insights
New GnRH-doxorubicin conjugates show promise for targeted cancer therapy. Conjugate II, targeting GnRH receptors, demonstrated enhanced efficacy and reduced toxicity in preclinical models, suggesting a novel strategy for treating GnRH receptor-positive tumors.
Area of Science:
- Oncology
- Pharmacology
- Bioconjugation Chemistry
Background:
- Gonadotropin-releasing hormone (GnRH) receptors are overexpressed in various tumors, unlike normal tissues.
- GnRH analogs can be utilized for targeted delivery of cytotoxic agents, potentially improving anticancer drug uptake and reducing side effects.
Purpose of the Study:
- To synthesize and evaluate novel GnRH-doxorubicin conjugates for targeted cancer chemotherapy.
- To assess the metabolic stability, antiproliferative activity, and targeting specificity of these conjugates.
Main Methods:
- Three GnRH analogs were conjugated with doxorubicin (Dox) using N-succinimidyl-3-maleimidopropionate linker.
- Metabolic stability was assessed using RP-HPLC in human serum.
- Antiproliferative activity was evaluated via MTT assay in GnRH receptor-positive MCF-7 cells and GnRH receptor-negative 3T3 cells.
Main Results:
- The synthesized GnRH-Dox conjugates exhibited improved metabolic stability compared to AN-152.
- Conjugate II ([d-Cys 6 , desGly 10 , Pro 9 -NHEt]-GnRH-Dox) displayed superior antiproliferative effects on MCF-7 cells than conjugates I and III.
- Conjugate II showed reduced cytotoxicity against 3T3 cells compared to free Dox, indicating targeted action.
Conclusions:
- Targeted delivery of conjugate II, mediated by [d-Cys 6 -des-Gly 10 -Pro 9 -NHEt]-GnRH, is a promising strategy for chemotherapy of tumors overexpressing GnRH receptors.
- This approach offers potential for enhanced efficacy and reduced systemic toxicity in cancer treatment.
Related Concept Videos
Stability of Conjugated Dienes
A comparison of the enthalpies of hydrogenation of dienes reveals that conjugated dienes release less heat on hydrogenation, rendering them more stable than their nonconjugated analogs.
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Conjugated Proteins
Nuclear Stability
To hold positively charged protons together...
RNA Stability
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability

